|
|
||||||||
Departments of 1 Clinical Pharmacology and 2 Experimental Pathology, University of Lund, S-221 85 Lund, Sweden; and 3 Salk Institute, La Jolla, California 92037
Nitric oxide (NO)-mediated
smooth muscle relaxation is mediated by cGMP through activation of
cGMP-dependent protein kinase I (cGKI). We studied the importance of
cGKI for lower urinary tract function in mice lacking the gene for cGKI
(cGKI
/
) and in litter-matched wild-type mice (cGKI+/+) in vitro and
in vivo. cGKI deficiency did not result in any changes in bladder gross morphology or weight. Urethral strips from cGKI
/
mice showed an
impaired relaxant response to nerve-derived NO. The cGMP analog 8-bromo-cGMP (8-BrcGMP) and the NO-donor SIN-1 relaxed the wild-type urethra (50-60%) but had only marginal effects in the
cGKI-deficient urethra. Bladder strips from cGKI
/
mice
responded normally to electrical field stimulation and to carbachol but
not to 8-BrcGMP. In vivo, the cGKI-deficient mice showed bladder
hyperactivity characterized by decreased intercontraction intervals and
nonvoiding bladder contractions. Loss of cGKI abolishes
NO-cGMP-dependent relaxations of urethral smooth muscle and results in
hyperactive voiding. These data suggest that certain voiding
disturbances may be associated with impaired NO-cGKI signaling.
nitric oxide synthase; transgenic; urethra; bladder; nonadrenergic, noncholinergic
This article has been cited by other articles:
![]() |
G. P. Sergeant, L. Johnston, N. G. McHale, K. D. Thornbury, and M. A. Hollywood Activation of the cGMP/PKG pathway inhibits electrical activity in rabbit urethral interstitial cells of Cajal by reducing the spatial spread of Ca2+ waves J. Physiol., July 1, 2006; 574(1): 167 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion Physiol Rev, January 1, 2006; 86(1): 1 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-E. Andersson and A. J. Wein Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence Pharmacol. Rev., December 1, 2004; 56(4): 581 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chang, J. A. Hypolite, M. Velez, A. Changolkar, A. J. Wein, S. Chacko, and M. E. DiSanto Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R950 - R960. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-E. Andersson and A. Arner Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology Physiol Rev, July 1, 2004; 84(3): 935 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Fitzpatrick and M. B. Sokolowski In Search of Food: Exploring the Evolutionary Link Between cGMP-Dependent Protein Kinase (PKG) and Behaviour Integr. Comp. Biol., February 1, 2004; 44(1): 28 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Feil, S. M. Lohmann, H. de Jonge, U. Walter, and F. Hofmann Cyclic GMP-Dependent Protein Kinases and the Cardiovascular System: Insights From Genetically Modified Mice Circ. Res., November 14, 2003; 93(10): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. DiSanto Corpus Cavernosum Smooth Muscle Physiology: A Role for Sex Hormones? J Androl, November 1, 2003; 24(6_suppl): S6 - S16. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |